Evidence map›Paper›PMID 41163567›Full record

ArticleHaematologica2026

Patient-centered care strategies for Jehovah's Witnesses with acute leukemia and high-grade myeloid neoplasms.

Jabra Zarka, Aref Al-Kali, Hassan B Alkhateeb, Aasiya Matin, Naseema Gangat, William J Hogan, James Foran, Hemant Murthy, Cecilia Arana Yi, Dhauna Karam Prasad and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jabra ZarkaDivision of Hematology, Mayo Clinic, Rochester, MN, USA, 55905; Division of Medical Oncology, Mayo Clinic, Rochester, MN. Zarka.jabra@mayo.edu.
Aref Al-KaliDivision of Hematology, Mayo Clinic, Rochester, MN.
Hassan B AlkhateebDivision of Hematology, Mayo Clinic, Rochester, MN.
Aasiya MatinDivision of Hematology, Mayo Clinic, Rochester, MN.
Naseema GangatDivision of Hematology, Mayo Clinic, Rochester, MN.
William J HoganDivision of Hematology, Mayo Clinic, Rochester, MN.
James ForanDivision of Hematology/Oncology, Mayo Clinic, Jacksonville, FL.
Hemant MurthyDivision of Hematology/Oncology, Mayo Clinic, Jacksonville, FL.
Cecilia Arana YiDivision of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ.
Dhauna Karam PrasadDivision of Hematology, Mayo Clinic, Rochester, MN, USA, 55905; Division of Medical Oncology, Mayo Clinic, Rochester, MN.
Syeda MinaDivision of Hematology, Mayo Clinic, Rochester, MN, USA, 55905; Division of Medical Oncology, Mayo Clinic, Rochester, MN.
Mark R LitzowDivision of Hematology, Mayo Clinic, Rochester, MN.
Kebede H BegnaDivision of Hematology, Mayo Clinic, Rochester, MN.
Antoine N SalibaDivision of Hematology, Mayo Clinic, Rochester, MN. Saliba.Antoine@mayo.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41163567
PMCPMC13040145

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.